Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
Discuss FDA-approved GLP-1 options (which may have insurance pathways) with your physician
Zheng, W., Pan, H., Wei, L., Gao, F
A clinical assessment can help you figure out whether GLP-1 therapy makes sense on its own or alongside other treatments
Tirzepatide for treating type 2 diabetes TA924
Even though the exact mechanism of action is not known, phlebotonics are thought to increase venous and lymphatic drainage, normalize capillary permeability and decrease inflammation in the hemorrhoidal cushions.4,1113 In a Cochrane review of 24 randomized controlled trials, Perera et al14 found that phlebotonics improved the outcomes of: Although phlebotonics give better results than placebo in the short-term management of hemorrhoids, there is a paucity of long-term data
